Literature DB >> 11839334

Infectious complications resulting from use of hemostatic puncture closure devices.

T P Smith1, C P Cruz, M M Moursi, J F Eidt.   

Abstract

BACKGROUND: Femoral access site complications have increased as the fields of invasive cardiology, radiology, and endovascular surgery have emerged. In order to address one of these complications, hemorrhage, the hemostatic puncture closure devices were developed.
METHODS: Retrospective review of cardiac catheterizations performed at a single institution to investigate infectious groin complications related to use of the Perclose Prostar and Techstar devices.
RESULTS: Infectious groin complications were significantly higher in the Perclose group as compared with manual compression. Three patients had clinical and laboratory evidence of arterial infection whereas 2 had soft tissue infections. All 5 required operative intervention ranging from incision and drainage to arterial reconstruction. Hemorrhagic complications were not significantly different between the two groups.
CONCLUSIONS: The Perclose devices provide hemostasis after femoral artery catheterization similar to manual compression. However, infectious groin complications appear to be more common with these devices.

Entities:  

Mesh:

Year:  2001        PMID: 11839334     DOI: 10.1016/s0002-9610(01)00806-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  Postinterventional percutaneous closure of femoral artery access sites using the Clo-Sur PAD device: initial findings.

Authors:  Jörn Oliver Balzer; Wolfram Schwarz; Axel Thalhammer; Katrin Eichler; Thomas Schmitz-Rixen; Thomas J Vogl
Journal:  Eur Radiol       Date:  2006-05-10       Impact factor: 5.315

Review 2.  Multidetector CT of iatrogenic and self-inflicted vascular lesions and infections at the groin.

Authors:  Massimo Tonolini; Anna Maria Ierardi; Gianpaolo Carrafiello; Domenico Laganà
Journal:  Insights Imaging       Date:  2018-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.